ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,446,783 | +10.9% | 93,813 | +2.9% | 0.00% | 0.0% |
| Q2 2023 | $4,909,943 | +184.0% | 91,212 | +109.5% | 0.00% | – |
| Q1 2023 | $1,729,000 | +109747.5% | 43,539 | +11.3% | 0.00% | – |
| Q4 2022 | $1,574 | -99.9% | 39,112 | +10.0% | 0.00% | – |
| Q3 2022 | $1,143,000 | +8.8% | 35,567 | +0.4% | 0.00% | – |
| Q2 2022 | $1,051,000 | +32.0% | 35,411 | +25.0% | 0.00% | – |
| Q1 2022 | $796,000 | -46.3% | 28,334 | -11.9% | 0.00% | – |
| Q4 2021 | $1,481,000 | +28.9% | 32,147 | -8.2% | 0.00% | – |
| Q3 2021 | $1,149,000 | -40.3% | 35,028 | -36.2% | 0.00% | – |
| Q2 2021 | $1,924,000 | -9.6% | 54,869 | -6.8% | 0.00% | – |
| Q1 2021 | $2,128,000 | +36.1% | 58,868 | +9.3% | 0.00% | – |
| Q4 2020 | $1,564,000 | +627.4% | 53,844 | +606.4% | 0.00% | – |
| Q3 2020 | $215,000 | -0.9% | 7,622 | +13.2% | 0.00% | – |
| Q2 2020 | $217,000 | -21.7% | 6,731 | -1.0% | 0.00% | – |
| Q1 2020 | $277,000 | -36.5% | 6,801 | -3.9% | 0.00% | – |
| Q4 2019 | $436,000 | -91.6% | 7,077 | -90.1% | 0.00% | -100.0% |
| Q3 2019 | $5,205,000 | +328.7% | 71,425 | +367.9% | 0.00% | – |
| Q2 2019 | $1,214,000 | +287.9% | 15,265 | +243.6% | 0.00% | – |
| Q1 2019 | $313,000 | -88.8% | 4,443 | -92.8% | 0.00% | -100.0% |
| Q4 2018 | $2,793,000 | -27.1% | 62,042 | -8.4% | 0.00% | 0.0% |
| Q3 2018 | $3,829,000 | +61.9% | 67,713 | +91.3% | 0.00% | – |
| Q2 2018 | $2,365,000 | +33.3% | 35,399 | +16.2% | 0.00% | – |
| Q1 2018 | $1,774,000 | -48.5% | 30,461 | -43.0% | 0.00% | -100.0% |
| Q4 2017 | $3,443,000 | -36.3% | 53,425 | -49.0% | 0.00% | 0.0% |
| Q3 2017 | $5,404,000 | +965.9% | 104,829 | +868.2% | 0.00% | – |
| Q2 2017 | $507,000 | -17.2% | 10,827 | -12.5% | 0.00% | – |
| Q1 2017 | $612,000 | -61.8% | 12,379 | -53.2% | 0.00% | – |
| Q4 2016 | $1,602,000 | +129.2% | 26,429 | +150.9% | 0.00% | – |
| Q3 2016 | $699,000 | +76.5% | 10,533 | +48.1% | 0.00% | – |
| Q2 2016 | $396,000 | +1220.0% | 7,110 | +704.3% | 0.00% | – |
| Q1 2016 | $30,000 | – | 884 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |